Nuveen Asset Management LLC Lowers Position in Health Catalyst, Inc. (NASDAQ:HCAT)

Nuveen Asset Management LLC lessened its position in Health Catalyst, Inc. (NASDAQ:HCAT) by 5.7% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 593,643 shares of the company’s stock after selling 35,645 shares during the quarter. Nuveen Asset Management LLC owned approximately 0.98% of Health Catalyst worth $4,197,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Quantbot Technologies LP purchased a new position in shares of Health Catalyst in the 4th quarter valued at approximately $29,000. Group One Trading LLC raised its stake in Health Catalyst by 107.6% during the fourth quarter. Group One Trading LLC now owns 4,360 shares of the company’s stock valued at $31,000 after buying an additional 2,260 shares during the last quarter. Aquatic Capital Management LLC purchased a new position in Health Catalyst during the fourth quarter valued at $63,000. Stoneridge Investment Partners LLC purchased a new position in Health Catalyst during the fourth quarter valued at $77,000. Finally, Martin Worley Group purchased a new position in Health Catalyst during the fourth quarter valued at $78,000. Hedge funds and other institutional investors own 85.00% of the company’s stock.

Insider Buying and Selling at Health Catalyst

In related news, General Counsel Benjamin Landry sold 13,827 shares of the business’s stock in a transaction on Thursday, March 6th. The shares were sold at an average price of $4.55, for a total transaction of $62,912.85. Following the completion of the transaction, the general counsel now owns 160,437 shares in the company, valued at approximately $729,988.35. The trade was a 7.93% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, COO Daniel Lesueur sold 16,902 shares of the stock in a transaction dated Wednesday, March 5th. The shares were sold at an average price of $4.52, for a total transaction of $76,397.04. Following the completion of the transaction, the chief operating officer now directly owns 216,250 shares of the company’s stock, valued at approximately $977,450. This trade represents a 7.25% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 41,147 shares of company stock valued at $182,284. Company insiders own 2.50% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have issued reports on HCAT. Stephens lowered their price objective on Health Catalyst from $7.00 to $5.00 and set an “equal weight” rating for the company in a research note on Thursday, March 6th. Canaccord Genuity Group decreased their price target on Health Catalyst from $10.00 to $9.00 and set a “buy” rating for the company in a research note on Thursday, May 8th. Evercore ISI cut Health Catalyst from an “outperform” rating to an “inline” rating in a research note on Wednesday, April 9th. Citigroup decreased their price target on Health Catalyst from $7.00 to $6.50 and set a “buy” rating for the company in a research note on Friday, April 25th. Finally, Piper Sandler decreased their price target on Health Catalyst from $12.00 to $8.00 and set an “overweight” rating for the company in a research note on Tuesday, February 11th. Three research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to data from MarketBeat.com, Health Catalyst currently has an average rating of “Moderate Buy” and a consensus price target of $8.00.

Health Catalyst Stock Up 1.1%

Health Catalyst stock opened at $3.78 on Friday. The stock has a market cap of $263.09 million, a PE ratio of -2.80 and a beta of 1.56. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.41 and a current ratio of 1.41. Health Catalyst, Inc. has a one year low of $3.49 and a one year high of $9.24. The stock has a fifty day moving average of $4.00 and a 200 day moving average of $5.49.

About Health Catalyst

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.